Pooled Analysis of Baricitinib Tolerability in Patients With Atopic Dermatitis in Relation to Acne, Headache, and Gastrointestinal Events From 8 Clinical Trials

ABSTRACT: BACKGROUND: Tolerability issues including acne, nausea, and headache have been reported with Janus kinase (JAK) inhibitors for moderate-to-severe atopic dermatitis (AD). OBJECTIVES: To report outcomes of tolerability adverse events (AEs) for baricitinib, a JAK1/JAK2 inhibitor, in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollenberg, Andreas, Kircik, Leon, Simpson, Eric, Brinker, Dennis, Katoh, Norito, Rueda, Maria Jose, Issa, Maher, Yang, Fan, Feely, Meghan, Alexis, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357532/
https://www.ncbi.nlm.nih.gov/pubmed/36749121
http://dx.doi.org/10.1089/derm.2022.0027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357532/
https://www.ncbi.nlm.nih.gov/pubmed/36749121
http://dx.doi.org/10.1089/derm.2022.0027

Ejemplares similares